Industry News
Pharmaceutical Industry News
Fierce Pharma Asia—Legend CSO’s departure; Takeda’s gene therapy deal; Pfizer’s India revamp
Fierce Pharma Asia—Legend CSO's departure; Takeda's gene therapy deal; Pfizer's India revamp aliu Fri, 04/08/2022 - 10:13
Vertex CEO Kewalramani nabs more than $15M in 2021 pay, rivaling some male Big Pharma peers
Vertex CEO Kewalramani nabs more than $15M in 2021 pay, rivaling some male Big Pharma peers fkansteiner Fri, 04/08/2022 - 10:13
NICE tells Gilead to cut Trodelvy’s price and rejects eczema meds from AbbVie, Pfizer and Leo
NICE tells Gilead to cut Trodelvy's price and rejects eczema meds from AbbVie, Pfizer and Leo kdunleavy Fri, 04/08/2022 - 09:30
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex fight
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex fight fkansteiner Fri, 04/08/2022 - 08:47
Biogen’s troubled Aduhelm hit with CMS slapdown—now what?
Biogen's troubled Aduhelm hit with CMS slapdown—now what? aliu Fri, 04/08/2022 - 06:34
AbbVie’s Rinvoq rockets up the pharma TV ad chart in March, but overall spend crashes back to Earth
AbbVie's Rinvoq rockets up the pharma TV ad chart in March, but overall spend crashes back to Earth badams Fri, 04/08/2022 - 02:54
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.
CMS sticks to its guns, limiting coverage of Biogen’s Aduhelm to clinical trials
CMS sticks to its guns, limiting coverage of Biogen's Aduhelm to clinical trials kdunleavy Thu, 04/07/2022 - 18:28
Despite TV ads, most asthma patients don’t recognize new biologic brands, but they’re willing to try them, a survey finds
Despite TV ads, most asthma patients don't recognize new biologic brands, but they're willing to try them, a survey finds nmissakian Thu, 04/07/2022 - 17:06
Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts
Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts kdunleavy Thu, 04/07/2022 - 14:33
On appeal, Pfizer and Merck KGaA convince England’s NICE to back Bavencio in bladder cancer
On appeal, Pfizer and Merck KGaA convince England's NICE to back Bavencio in bladder cancer aliu Thu, 04/07/2022 - 11:30
Pfizer rolls out voluntary retirement scheme in India as it dives deeper into digital
Pfizer rolls out voluntary retirement scheme in India as it dives deeper into digital fkansteiner Thu, 04/07/2022 - 11:05
Alnylam founder Maraganore snags $10.2M pay in his farewell year, as new CEO Greenstreet grabs $8.6M
Alnylam founder Maraganore snags $10.2M pay in his farewell year, as new CEO Greenstreet grabs $8.6M aliu Thu, 04/07/2022 - 09:57
Superior Patient Engagement – A “Must Have” For Biopharma
Superior Patient Engagement – A “Must Have” For Biopharma ncavazza Thu, 04/07/2022 - 09:51
A seasonal COVID-19 booster shot? Don’t count on it in the U.S. or Europe
A seasonal COVID-19 booster shot? Don't count on it in the U.S. or Europe kdunleavy Thu, 04/07/2022 - 09:28
Asymchem completes construction at new Chinese production sites
Asymchem completes construction at new Chinese production sites jkeenan Thu, 04/07/2022 - 09:12
Akebia reveals sweeping layoffs and vadadustat partial clinical hold after FDA snub
Akebia reveals sweeping layoffs and vadadustat partial clinical hold after FDA snub fkansteiner Thu, 04/07/2022 - 09:00
Catalent buys partially built biologics plant with plans to shell out $160M to finish it
Catalent buys partially built biologics plant with plans to shell out $160M to finish it jkeenan Thu, 04/07/2022 - 08:30
With €7B pledge, Boehringer Ingelheim is going heavy on investment—including in manufacturing
With €7B pledge, Boehringer Ingelheim is going heavy on investment—including in manufacturing kdunleavy Wed, 04/06/2022 - 15:50
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.